Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses.

Rheumatology (Oxford, England) - 3 Apr 2023

Breillat Paul, Mariampillai Kuberaka, Legendre Paul, Martins Pauline, Dunogue Bertrand, Charuel Jean Luc, Miyara Makoto, Goulvestre Claire, Paule Romain, Vanquaethem Helene, Ackermann Felix, Benveniste Olivier, Nunes Hilario, Mouthon Luc, Allenbach Yves, Uzunhan Yurdagul

Abstract excerpt

OBJECTIVE: To help identify homogeneous subgroups among patients with anti-PM-scleroderma-antibodies (PM-Scl-Abs) positive auto-immune diseases regardless of diagnostic classifications. MATERIAL AND METHODS: This multicentric (four hospitals) retrospective study collected all consecutive patients (from 2011 to 2021) with positive testing for anti-PM-Scl-Abs in a context of CTD. Subgroups of patients with similar...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Lung Diseases, Interstitial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Prognosis

Source

Identifiers

PMID: 36063462
DOI: 10.1093/rheumatology/keac508

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses.PMID 36063462Read ↗

Clinical profiles associated with rapidly progressive interstitial lung disease in antisynthetase syndrome: A multicentric cohort study (TYPASS study).Semantic proximity Read ↗

A new proposal for phenotypic classification and outcome assessment of dermatomyositis based on clinical manifestations and serological testing.Semantic proximity Read ↗

Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doors.Semantic proximity Read ↗

Connective Tissue Disease-Associated Interstitial Lung Diseases: Unresolved Issues.Semantic proximity Read ↗

Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin.Semantic proximity Read ↗

Correlation between lung microecology and immunity in patients with anti-MDA5 antibody-positive dermatomyositis combined with interstitial lung disease: protocol for a prospective, multicentre cohort studySemantic proximity Read ↗

The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.Semantic proximity Read ↗

Clinical and molecular characterization of ILD in patients with overlapping ASyS and SjD: a retrospective observational study.Semantic proximity Read ↗

Autoimmune-Associated Interstitial Lung Disease: Imaging Phenotypes.Semantic proximity Read ↗

Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren’s SyndromeSemantic proximity Read ↗

Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease.Semantic proximity Read ↗

Phenotypic subtypes of fibrotic hypersensitivity pneumonitis identified by machine learning consensus clustering analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.